Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.

Abstract:

:Previous studies have demonstrated a synergistic interaction between rhuMAb HER2 and the cytotoxic drug cisplatin in human breast and ovarian cancer cells. To define the nature of the interaction between rhuMAb HER2 and other classes of cytotoxic drugs, we applied multiple drug effect/combination index (CI) isobologram analysis to a variety of chemotherapeutic drug/rhuMAb HER2 combinations in vitro. Synergistic interactions at clinically relevant drug concentrations were observed for rhuMAb HER2 in combination with cisplatin (CI=0.48, P=0.003), thiotepa (CI=0.67, P=0.0008), and etoposide (CI=0.54, P=0.0003). Additive cytotoxic effects were observed with rhuMAb HER2 plus doxorubicin (CI=1.16, P=0.13), paclitaxel (CI=0.91, P=0.21), methotrexate (CI=1.15, P=0.28), and vinblastine (CI=1.09, P=0.26). One drug, 5-fluorouracil, was found to be antagonistic with rhuMAb HER2 in vitro (CI=2.87, P=0.0001). In vivo drug/rhuMAb HER2 studies were conducted with HER-2/neu-transfected, MCF7 human breast cancer xenografts in athymic mice. Combinations of rhuMAb HER2 plus cyclophosphamide, doxorubicin, paclitaxel, methotrexate, etoposide, and vinblastine in vivo resulted in a significant reduction in xenograft volume compared to chemotherapy alone (P<0.05). Xenografts treated with rhuMAb HER2 plus 5-fluorouracil were not significantly different from 5-fluorouracil alone controls consistent with the subadditive effects observed with this combination in vitro. The synergistic interaction of rhuMAb HER2 with alkylating agents, platinum analogs and topoisomerase II inhibitors, as well as the additive interaction with taxanes, anthracyclines and some antimetabolites in HER-2/neu-overexpressing breast cancer cells demonstrates that these are rational combinations to test in human clinical trials.

journal_name

Oncogene

journal_title

Oncogene

authors

Pegram M,Hsu S,Lewis G,Pietras R,Beryt M,Sliwkowski M,Coombs D,Baly D,Kabbinavar F,Slamon D

doi

10.1038/sj.onc.1202526

subject

Has Abstract

pub_date

1999-04-01 00:00:00

pages

2241-51

issue

13

eissn

0950-9232

issn

1476-5594

journal_volume

18

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1.

    abstract::Although increasing evidence indicated that the deregulation of microRNAs (miRNAs) contributes to tumorigenesis and invasion, little is known about the role of miR-637 in human gliomas. In the present study, we found that the expression level of miR-637 was significantly reduced in clinical glioma tissues compared wit...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.419

    authors: Que T,Song Y,Liu Z,Zheng S,Long H,Li Z,Liu Y,Wang G,Liu Y,Zhou J,Zhang X,Fang W,Qi S

    更新日期:2015-09-17 00:00:00

  • Characterization of VIK-1: a new Vav-interacting Kruppel-like protein.

    abstract::Binding partners of the Src homology domains of Vav-1 were characterized by a two-hybrid screening of a Jurkat cell cDNA library. One of the isolated clones encoded a new protein named VIK that belongs to the Kruppel-like zinc-finger gene family. Genome mapping showed that a single gene positioned at chromosome 7q22.1...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208043

    authors: Houlard M,Romero-Portillo F,Germani A,Depaux A,Regnier-Ricard F,Gisselbrecht S,Varin-Blank N

    更新日期:2005-01-06 00:00:00

  • Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells.

    abstract::A potential role for 1-oleoyl-sn-glycero-3-phosphate or lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) in the regulation of malignant diseases has been widely considered. In this study, we found that in transformed astroglial cells, the expression profile of lysophospholipid receptor mRNA and the action...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208805

    authors: Malchinkhuu E,Sato K,Horiuchi Y,Mogi C,Ohwada S,Ishiuchi S,Saito N,Kurose H,Tomura H,Okajima F

    更新日期:2005-10-06 00:00:00

  • Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.

    abstract::There is increasing evidence that mast cells (MCs) and their mediators are involved in the remodeling of the tumor microenvironment and promote tumor growth, angiogenesis and metastasis. We have found that an increased density of MCs in thyroid cancer (TC) correlates with enhanced invasiveness. However, the MC-derived...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.441

    authors: Visciano C,Liotti F,Prevete N,Cali' G,Franco R,Collina F,de Paulis A,Marone G,Santoro M,Melillo RM

    更新日期:2015-10-01 00:00:00

  • p53 point mutation in HPV negative human cervical carcinoma cell lines.

    abstract::Clinical and experimental evidence is consistent with a key role for transforming human papilloma viruses (HPVs) in the aetiology of anogenital carcinoma. Cervical carcinoma does, however, occasionally occur in the absence of HPV sequences (Riou et al., 1990). We have used a direct cDNA/PCR sequencing protocol to anal...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Crook T,Wrede D,Vousden KH

    更新日期:1991-05-01 00:00:00

  • The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.

    abstract::A recent large multi-centre study convincingly confirmed previous observations that the SYT-SSX1 fusion type, compared to SYT-SSX2, of synovial sarcoma is associated with a worse clinical outcome. Apart from the clinical impact, this fact also suggests (1) that the SYT-SSX fusion gene may influence molecular mechanism...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205700

    authors: Xie Y,Skytting B,Nilsson G,Grimer RJ,Mangham CD,Fisher C,Shipley J,Bjerkehagen B,Myklebost O,Larsson O

    更新日期:2002-08-22 00:00:00

  • Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.

    abstract::O6-methylguanine-DNA methyltransferase (MGMT) repairs the cytotoxic and mutagenic O6-alkylguanine produced by alkylating agents such as chemotherapeutic agents and mutagens. Recent studies have shown that in a subset of tumors, MGMT expression is inversely linked to hypermethylation of the CpG island in the promoter r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207183

    authors: Nakagawachi T,Soejima H,Urano T,Zhao W,Higashimoto K,Satoh Y,Matsukura S,Kudo S,Kitajima Y,Harada H,Furukawa K,Matsuzaki H,Emi M,Nakabeppu Y,Miyazaki K,Sekiguchi M,Mukai T

    更新日期:2003-12-04 00:00:00

  • Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

    abstract::Mantle cell lymphoma (MCL) is characterized by 11q13 chromosomal translocation and CCND1 overexpression, but additional genomic changes are also important for lymphomagenesis. To identify the genomic aberrations of MCL at higher resolutions, we analysed 29 patient samples and seven cell lines using array-based compara...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208300

    authors: Tagawa H,Karnan S,Suzuki R,Matsuo K,Zhang X,Ota A,Morishima Y,Nakamura S,Seto M

    更新日期:2005-02-17 00:00:00

  • Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling.

    abstract::Tumors of low malignant potential (LMP) represent 20% of epithelial ovarian cancers (EOCs) and are associated with a better prognosis than the invasive tumors (TOV). Defining the relationship between LMPs and TOVs remains an important goal towards understanding the molecular pathways that contribute to prognosis, as w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208214

    authors: Ouellet V,Provencher DM,Maugard CM,Le Page C,Ren F,Lussier C,Novak J,Ge B,Hudson TJ,Tonin PN,Mes-Masson AM

    更新日期:2005-07-07 00:00:00

  • MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.

    abstract::Murine double minute (MDM2) binding protein (MTBP) has been implicated in cancer progression. Here, we demonstrate one mechanism by which MTBP inhibits cancer metastasis. Overexpression of MTBP in human osteosarcoma cell lines lacking wild-type p53 did not alter primary tumor growth in mice, but significantly inhibite...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.69

    authors: Agarwal N,Adhikari AS,Iyer SV,Hekmatdoost K,Welch DR,Iwakuma T

    更新日期:2013-01-24 00:00:00

  • CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradation.

    abstract::Protein kinase CK2 is a ubiquitous and pleiotropic Ser/Thr protein kinase involved in cell growth and transformation. Here we report the identification by yeast interaction trap of a CK2 interacting protein, UBC3B, which is highly homologous to the E2 ubiquitin conjugating enzyme UBC3/CDC34. UBC3B complements the yeas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205574

    authors: Semplici F,Meggio F,Pinna LA,Oliviero S

    更新日期:2002-06-06 00:00:00

  • Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.

    abstract::Rearrangements of the NFKB2 gene are associated with lymphoid malignancies, but the functional significance of these alterations is not known. Here we characterize structurally and functionally a rearranged NFKB2 gene identified at the T cell lymphoma line, HUT78. The rearrangement has truncated NFKB2 sequences within...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zhang J,Chang CC,Lombardi L,Dalla-Favera R

    更新日期:1994-07-01 00:00:00

  • Isolation of chromosome-specific DNA sequences from an Alu polymerase chain reaction library to define the breakpoint in a patient with a constitutional translocation t(1;13) (q22;q12) and ganglioneuroblastoma.

    abstract::We describe the cytogenetic and molecular characterization of a t(1;13)(q22;q12) constitutional rearrangement occurring in a patient with a relatively benign form of neuroblastoma, called ganglioneuroblastoma. Somatic cell hybrids were generated between mouse 3T3 cells and a lymphoblastoid cell line from this patient,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Michalski AJ,Cotter FE,Cowell JK

    更新日期:1992-08-01 00:00:00

  • Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1.

    abstract::Histone acetylation has a central role in establishing an active chromatin environment. The functional contribution of histone acetylation to chromatin transcription is accomplished by a dominant action of histone acetyltransferases over repressive histone-modifying activities at gene promoters; misregulation of these...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.273

    authors: Heo K,Kim JS,Kim K,Kim H,Choi J,Yang K,An W

    更新日期:2013-05-16 00:00:00

  • The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis.

    abstract::Cytokinesis is the final step of cell division. Increasing evidence suggests failure of cytokinesis might contribute to the development of cancer. Here, we demonstrate that the serologically defined colon cancer antigen-3 (SDCCAG3) forms a complex with PTPN13, a protein tyrosine phosphatase known to be involved in the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.485

    authors: Hagemann N,Ackermann N,Christmann J,Brier S,Yu F,Erdmann KS

    更新日期:2013-09-26 00:00:00

  • The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility.

    abstract::Cell migration is an integral component of metastatic disease. The ability of cells to transit between mesenchymal and amoeboid modes of migration has complicated the development of successful therapies designed to target cell migration as a means of inhibiting metastasis. Therefore, investigations of the mechanisms t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.516

    authors: Lees JG,Bach CT,Bradbury P,Paul A,Gunning PW,O'Neill GM

    更新日期:2011-03-10 00:00:00

  • Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.

    abstract::Signature abnormalities in the cell cycle and apoptotic pathway have been identified in mantle cell lymphoma (MCL), affording the opportunity to develop targeted therapies. In this study, we tested a novel class of kinase inhibitors, styryl sulfones, which differ from prior cell cycle inhibitors in that they are not r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210350

    authors: Park IW,Reddy MV,Reddy EP,Groopman JE

    更新日期:2007-08-16 00:00:00

  • C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy.

    abstract::Oncolytic adenoviruses, such as Delta-24-RGD (Δ24RGD), are replication-competent viruses that are genetically engineered to induce selective cancer cell lysis. In cancer cells, Δ24RGD induces massive autophagy, which is required for efficient cell lysis and adenoviral spread. Understanding the cellular mechanisms unde...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.452

    authors: Klein SR,Piya S,Lu Z,Xia Y,Alonso MM,White EJ,Wei J,Gomez-Manzano C,Jiang H,Fueyo J

    更新日期:2015-10-08 00:00:00

  • Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.

    abstract::Mice transgenic for the leukemia oncogene E2A-PBX1 invariably develop lethal, high-grade T-cell lymphomas by 5 months of age. In this study, retroviral insertional mutagenesis was employed to identify oncogenes that cooperate with the E2A-PBX1 transgene in lymphomagenesis. Neonatal retroviral infection substantially r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201670

    authors: Feldman BJ,Reid TR,Cleary ML

    更新日期:1997-11-27 00:00:00

  • Endoreplication in megakaryoblastic cell lines is accompanied by sustained expression of G1/S cyclins and downregulation of cdc25C.

    abstract::In most eukaryotic cells, a link between S and M phases of the cell cycle must be assured in order to maintain the ploidy of newly divided cells. However, in some cell l/pes, e.g. the precursors of platelets megakaryocytes, extra S-phases can occur in the absence of concomitant mitoses, resulting in polyploidy. We hav...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: García P,Calés C

    更新日期:1996-08-15 00:00:00

  • Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.

    abstract::While studying Bim, a BH3-only proapoptotic protein, we identified an approximately 36 kDa protein, which was abundantly expressed in all five strains of primary normal human prostate (NHP) epithelial cells but significantly reduced or lost in seven prostate cancer cell lines. The approximately 36 kDa protein was subs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206196

    authors: Liu JW,Shen JJ,Tanzillo-Swarts A,Bhatia B,Maldonado CM,Person MD,Lau SS,Tang DG

    更新日期:2003-03-13 00:00:00

  • Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.

    abstract::Early studies demonstrated that male melanoma patients have worse survival than female patients, yet the detailed mechanisms for this gender difference remain unclear. We analyzed around 100 cases of human melanoma and found that androgen receptor (AR) positive melanoma patients have worse survival outcomes compared w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.330

    authors: Wang Y,Ou Z,Sun Y,Yeh S,Wang X,Long J,Chang C

    更新日期:2017-03-23 00:00:00

  • The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription.

    abstract::BAG-1 is a multifunctional protein that interacts with a wide range of cellular targets including heat-shock proteins and some nuclear hormone receptors. BAG-1 exists as three major isoforms, BAG-1L, BAG-1M and BAG-1S. BAG-1L contains a nuclear localization signal, which is not present in the other isoforms, and is pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206688

    authors: Cutress RI,Townsend PA,Sharp A,Maison A,Wood L,Lee R,Brimmell M,Mullee MA,Johnson PW,Royle GT,Bateman AC,Packham G

    更新日期:2003-08-07 00:00:00

  • AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu.

    abstract::The anti-p185(her2/neu) peptidomimetic (AHNP) is a small exo-cyclic peptide derived from the anti-p185(her2/neu) rhumAb 4D5 (h4D5). AHNP mimics many but not all of the antitumor characteristics exhibited by h4D5. However, the pharmacokinetic profiles of AHNP are less than optimal for therapeutic or diagnostic purposes...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209745

    authors: Masuda K,Richter M,Song X,Berezov A,Masuda K,Murali R,Greene MI,Zhang H

    更新日期:2006-12-14 00:00:00

  • Identification of genomic DNA sequences bound by mutant p53 protein (Gly245-->Ser) in vivo.

    abstract::Mutant p53 proteins were shown to exert complex DNA-interactions in vitro, like binding to MAR-DNA, but so far it is unknown whether such interactions also occur in vivo. Therefore we analysed the binding of mutant (mut) p53 (Gly245-->Ser) in Onda 11 glioma cells to cellular DNA in vivo, using p53-specific chromatin i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203745

    authors: Koga H,Deppert W

    更新日期:2000-08-24 00:00:00

  • Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.

    abstract::The most common genetic alteration identified in transitional cell carcinoma (TCC) of the bladder is loss of heterozygosity (LOH) on chromosome 9. However, localization of tumor suppressor genes on 9q has been hampered by the low frequency of subchromosomal deletions. We have analysed 139 primary, initial low stage TC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202277

    authors: Simoneau M,Aboulkassim TO,LaRue H,Rousseau F,Fradet Y

    更新日期:1999-01-07 00:00:00

  • AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.

    abstract::Polyamines are critical elements in mammals, but it remains unknown whether adenosyl methionine decarboxylase (AMD1), a rate-limiting enzyme in polyamine synthesis, is required for myeloid leukemia. Here, we found that leukemic stem cells (LSCs) were highly differentiated, and leukemia progression was severely impaire...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01547-x

    authors: Sari IN,Yang YG,Wijaya YT,Jun N,Lee S,Kim KS,Bajaj J,Oehler VG,Kim SH,Choi SY,Park SH,Kim DW,Reya T,Han J,Kwon HY

    更新日期:2021-01-01 00:00:00

  • Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.

    abstract::Prostate stem cell antigen (PSCA) is a recently defined homologue of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. PSCA mRNA is expressed in the basal cells of normal prostate and in more than 80% of prostate cancers. The purpose of the present study was to examine PSCA pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203426

    authors: Gu Z,Thomas G,Yamashiro J,Shintaku IP,Dorey F,Raitano A,Witte ON,Said JW,Loda M,Reiter RE

    更新日期:2000-03-02 00:00:00

  • The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action.

    abstract::The p160 nuclear receptor co-activators represent a family of molecules, which are recruited by steroid nuclear receptors as well as other transcription factors that are overexpressed in several tumors. We investigated the role of one member of this family on the sensitivity of cells to apoptosis. We observed that ove...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210900

    authors: Colo GP,Rubio MF,Nojek IM,Werbajh SE,Echeverría PC,Alvarado CV,Nahmod VE,Galigniana MD,Costas MA

    更新日期:2008-04-10 00:00:00

  • Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.

    abstract::Triple negative breast cancer (TNBC) refers to tumors that do not express clinically significant levels of estrogen and progesterone receptors, and lack membrane overexpression or gene amplification of ErbB-2/HER2, a receptor tyrosine kinase. Transcriptome and proteome heterogeneity of TNBC poses a major challenge to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01430-9

    authors: Chervo MF,Cordo Russo RI,Petrillo E,Izzo F,De Martino M,Bellora N,Cenciarini ME,Chiauzzi VA,Santa María de la Parra L,Pereyra MG,Güttlein LN,Podhajcer OL,Daniotti JL,Dupont A,Barchuk S,Figurelli S,Lopez Della Vecchia D,

    更新日期:2020-09-01 00:00:00